JP Morgan Chase
DMTK

JP Morgan Chase’s DermTech, Inc. Common Stock DMTK Stock Holding History

JP Morgan Chase’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9,400
Closed -$477K – 6682
2021
Q1 		$477K Buy
+9,400
New +$492K ﹤0.01% 4713

Other funds holding DMTK

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

JP Morgan Chase's DMTK Position: Q2 2024 in Review

JP Morgan Chase sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 129 shares — an estimated $91 sold.

JP Morgan Chase first reported a position in DMTK in Q2 2020 and held it in 16 quarters. The position peaked at $1.51M in Q3 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • JP Morgan Chase reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • JP Morgan Chase sold 129 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $91.
  • JP Morgan Chase first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • JP Morgan Chase's DermTech, Inc. Common Stock position peaked at $1.51M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.